Ranked by rounds participated in, from announcements in Sep 28, 2026 – Oct 27, 2026. Lead counts include only confirmed lead roles.
New companies 17 · Follow-on 0
Stages: Undisclosed 17
Epyr Undisclosed Selected for grant agreement preparationReverion Undisclosed Selected for grant agreement preparationH2SITE Undisclosed Selected for grant agreement preparationNew companies 7 · Follow-on 0
Stages: Undisclosed 7
Riverlane Undisclosed Planned strategic investmentForesight Undisclosed Planned strategic investmentHiverge Undisclosed Planned strategic investmentNew companies 5 · Follow-on 0
Stages: Series A 2, Seed 1, Series B 1, Series C+ 1
Nouscom €120M Series DCarbonFarm €7M Series AEdonia €15M Series A financing package including non-dilutive and bank fundingNew companies 4 · Follow-on 0
Stages: Seed 2, Pre-seed 1, Undisclosed 1
Marrow $2M Pre-seedIMMIX $3.5M UndisclosedCleavr €8M SeedNew companies 4 · Follow-on 0
Stages: Undisclosed 2, Pre-seed 1, Seed 1
Emerald £1.4M Grant and venture fundingGo Eve Undisclosed UndisclosedAffinity Labs $2M Pre-seed funding including grantNew companies 4 · Follow-on 0
Stages: Series C+ 2, Series B 1, Undisclosed 1
Microbiotica £36M Series C first closeOMass Therapeutics $310M Series CSalience Labs $125M Series BNew companies 3 · Follow-on 1
Stages: Undisclosed 3, Series A 1
PSV Tech Fund II €56M Fund II, final close October 2026Rodinia Generation €4M Investment roundSovera Security DKK 4M EIFO match loanNew companies 2 · Follow-on 1
Stages: Series C+ 2, Series B 1
Nevis $70M Series BPigment $250M Series ELegora $550M Series ENew companies 3 · Follow-on 0
Stages: Seed 1, Series A 1, Undisclosed 1
adsilico £10M Series ASilvia Bio £3M SeedMatter Machine £4M Pre-Series ANew companies 3 · Follow-on 0
Stages: Seed 1, Series C+ 1, Undisclosed 1
Phononic Vibes Undisclosed Financing transaction including secondary share purchaseNouscom €120M Series DAptadir Therapeutics €40M SeedNew companies 3 · Follow-on 0
Stages: Pre-seed 3
Jenz €540K Pre-seedAffinity Labs $2M Pre-seed funding including grantCodeWall $4M Pre-seedNew companies 2 · Follow-on 1
Stages: Series A 1, Series B 1, Undisclosed 1
Opply $7.5M UndisclosedDuvo $32M Series ASpiko $90M Series BNew companies 3 · Follow-on 0
Stages: Seed 2, Undisclosed 1
Opply $7.5M UndisclosedCori Clinical $4M SeedNettle $4.8M SeedNew companies 2 · Follow-on 1
Stages: Pre-seed 2, Series C+ 1
Vessla $3.3M Pre-seedSolvera $6.3M Pre-seedMetaview $60M Series CNew companies 2 · Follow-on 1
Stages: Series A 1, Series B 1, Series C+ 1
OMass Therapeutics $310M Series CAnaCardio €62.5M Series BBreye Therapeutics €67.5M Series ANew companies 2 · Follow-on 1
Stages: Seed 1, Series A 1, Undisclosed 1
Ambio €5.1M Seed1KOMMA5° ~€70M Equity financingProcuros €20M Series ANew companies 3 · Follow-on 0
Stages: Pre-seed 1, Seed 1, Series B 1
Rabot Energy $50M Series BTODAY €2.8M SeedFinches €2M Pre-seedNew companies 3 · Follow-on 0
Stages: Series B 2, Seed 1
Rabot Energy $50M Series BRivercell $25M SeedHadrian $40M Series BNew companies 2 · Follow-on 1
Stages: Seed 1, Series A 1, Series B 1
Causa Prima $20M SeedScarlet $50M Series BProcuros €20M Series ANew companies 3 · Follow-on 0
Stages: Undisclosed 2, Seed 1
Wavo €10M Equity financing1KOMMA5° ~€70M Equity financingComplaion €13.5M SeedNew companies 3 · Follow-on 0
Stages: Seed 1, Series A 1, Undisclosed 1
HyLight €13M Funding roundSensible Biotechnologies $47M Series ARevnu $3M SeedNew companies 3 · Follow-on 0
Stages: Pre-seed 1, Seed 1, Series A 1
Sensible Biotechnologies $47M Series AFoundational £8.2M Pre-seedZenithon AI $10M SeedNew companies 2 · Follow-on 1
Stages: Pre-seed 2, Seed 1
Cleavr €8M SeedFleuret AI €4M Pre-seedDoD Solution $2.1M Pre-SeedNew companies 1 · Follow-on 1
Stages: Series B 1, Undisclosed 1
Nevis $70M Series BRobCo Undisclosed Primary investment and employee secondary transactionNew companies 2 · Follow-on 0
Stages: Undisclosed 2
CHD (Connected Health Development) CHF 150K Venture Kick convertible financingRheoCarti CHF 150K Venture Kick support“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.